With 17 years in the market, and 35 years of R&D, the company is a family enterprise specialized in the development of non allopathic medicine for veterinary use. Possessing its own technology, the medicine is destined to the treatment of the main pathology and the acceleration of animal development for birds, fishes, cattle, horses, swine, sheep, goats and others. The company has a strong presence in the endecto segment. The company has more than 100 registered patents, composing a complete